The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Cancer Cell

Volumn 33, Issue 4, 2018, Pages 570-580

  Gopalakrishnan, Vancheswaran ^a   Helmink, Beth A ^a   Spencer, Christine N ^a   Reuben, Alexandre ^a   Wargo, Jennifer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cancer; cancer immunosurveillance; gut microbiome; immunity; immunotherapy; immunotherapy response; immunotherapy toxicity; microbiome; microbiome manipulation; microbiota

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT; PROBIOTIC AGENT;

CANCER IMMUNOTHERAPY; CANCER THERAPY; FECAL MICROBIOTA TRANSPLANTATION; IMMUNE RESPONSE; IMMUNITY; IMMUNOSURVEILLANCE; INTESTINE FLORA; MALIGNANT NEOPLASM; MICROBIAL CONSORTIUM; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; BACTERIUM; CLINICAL TRIAL (TOPIC); HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; IMMUNOTHERAPY; MICROBIOLOGY; NEOPLASM; PERSONALIZED MEDICINE; PROCEDURES;

BACTERIA; CLINICAL TRIALS AS TOPIC; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOTHERAPY; MONITORING, IMMUNOLOGIC; NEOPLASMS; PRECISION MEDICINE; PROBIOTICS;

EID: 85044739809     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.03.015     Document Type: Review

References (71)

1. Abt, M.C., Osborne, L.C., Monticelli, L.A., Doering, T.A., Alenghat, T., Sonnenberg, G.F., Paley, M.A., Antenus, M., Williams, K.L., Erikson, J., Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37 (2012), 158–170.
2. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
3. Benus, R.F., van Der Werf, T.S., Welling, G.W., Judd, P.A., Taylor, M.A., Harmsen, H.J., Whelan, K., Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br. J. Nutr. 104 (2010), 693–700.
4. Berman, D., Parker, S.M., Siegel, J., Chasalow, S.D., Weber, J., Galbraith, S., Targan, S.R., Wang, H.L., Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun., 10, 2010, 11.
5. Biagi, E., Zama, D., Nastasi, C., Consolandi, C., Fiori, J., Rampelli, S., Turroni, S., Centanni, M., Severgnini, M., Peano, C., et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant. 50 (2015), 992–998.
6. Blank, C.U., Haanen, J.B., Ribas, A., Schumacher, T.N., CANCER IMMUNOLOGY. The “cancer immunogram”. Science 352 (2016), 658–660.
7. Borody, T.J., Warren, E.F., Leis, S.M., Surace, R., Ashman, O., Siarakas, S., Bacteriotherapy using fecal flora: toying with human motions. J. Clin. Gastroenterol. 38 (2004), 475–483.
8. Cahn, J.Y., Klein, J.P., Lee, S.J., Milpied, N., Blaise, D., Antin, J.H., Leblond, V., Ifrah, N., Jouet, J.P., Loberiza, F., et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 106 (2005), 1495–1500.
9. Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann. Oncol. 28 (2017), 1368–1379.
10. Chen, D.S., Mellman, I., Oncology meets immunology: the cancer-immunity cycle. Immunity 39 (2013), 1–10.
11. Chen, D.S., Mellman, I., Elements of cancer immunity and the cancer-immune set point. Nature, 541, 2017, 321.
12. Cogdill, A.P., Andrews, M.C., Wargo, J.A., Hallmarks of response to immune checkpoint blockade. Br. J. Cancer 117 (2017), 1–7.
13. Consoli, M.L., da Silva, R.S., Nicoli, J.R., Bruña-Romero, O., da Silva, R.G., de Vasconcelos Generoso, S., Correia, M.I., Randomized clinical trial: impact of oral administration of Saccharomyces boulardii on gene expression of intestinal cytokines in patients undergoing colon resection. JPEN J Parenter. Enteral Nutr. 40 (2016), 1114–1121.
14. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
15. Dubin, K., Callahan, M.K., Ren, B., Khanin, R., Viale, A., Ling, L., No, D., Gobourne, A., Littmann, E., Huttenhower, C., et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun., 7, 2016, 10391.
16. Faith, J.J., Ahern, P.P., Ridaura, V.K., Cheng, J., Gordon, J.I., Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med., 6, 2014, 220ra11.
17. Frankel, A.E., Coughlin, L.A., Kim, J., Froehlich, T.W., Xie, Y., Frenkel, E.P., Koh, A.Y., Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia 19 (2017), 848–855.
18. Frosali, S., Pagliari, D., Gambassi, G., Landolfi, R., Pandolfi, F., Cianci, R., How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology. J. Immunol. Res., 2015, 2015, 489821.
19. Gerbitz, A., Schultz, M., Wilke, A., Linde, H.J., Scholmerich, J., Andreesen, R., Holler, E., Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103 (2004), 4365–4367.
20. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
21. Heimesaat, M.M., Nogai, A., Bereswill, S., Plickert, R., Fischer, A., Loddenkemper, C., Steinhoff, U., Tchaptchet, S., Thiel, E., Freudenberg, M.A., et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59 (2010), 1079–1087.
22. Hibberd, A.A., Lyra, A., Ouwehand, A.C., Rolny, P., Lindegren, H., Cedgård, L., Wettergren, Y., Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol., 4, 2017, e000145.
23. Hirota, K., Duarte, J.H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D.J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12 (2011), 255–263.
24. Holler, E., Butzhammer, P., Schmid, K., Hundsrucker, C., Koestler, J., Peter, K., Zhu, W., Sporrer, D., Hehlgans, T., Kreutz, M., et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol. Blood Marrow Transplant. 20 (2014), 640–645.
25. Honda, K., Littman, D.R., The microbiota in adaptive immune homeostasis and disease. Nature 535 (2016), 75–84.
26. Huda, M.N., Lewis, Z., Kalanetra, K.M., Rashid, M., Ahmad, S.M., Raqib, R., Qadri, F., Underwood, M.A., Mills, D.A., Stephensen, C.B., Stool microbiota and vaccine responses of infants. Pediatrics 134 (2014), e362–e372.
27. Huys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J.J., Daube, G., Microbial characterization of probiotics – advisory report of the working group “8651 probiotics” of the belgian superior health council (SHC). Mol. Nutr. Food Res. 57 (2013), 1479–1504.
28. Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A., Salcedo, R., Back, T., Cramer, S., et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342 (2013), 967–970.
29. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
30. Ivanov, I.I., Frutos Rde, L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., Finlay, B.B., Littman, D.R., Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4 (2008), 337–349.
31. Jacobsohn, D.A., Vogelsang, G.B., Acute graft versus host disease. Orphanet J. Rare Dis., 2, 2007, 35.
32. Jenq, R.R., Taur, Y., Devlin, S.M., Ponce, D.M., Goldberg, J.D., Ahr, K.F., Littmann, E.R., Ling, L., Gobourne, A.C., Miller, L.C., et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol. Blood Marrow Transplant. 21 (2015), 1373–1383.
33. Jenq, R.R., Ubeda, C., Taur, Y., Menezes, C.C., Khanin, R., Dudakov, J.A., Liu, C., West, M.L., Singer, N.V., Equinda, M.J., et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209 (2012), 903–911.
34. Johansson, M.E., Jakobsson, H.E., Holmen-Larsson, J., Schutte, A., Ermund, A., Rodriguez-Pineiro, A.M., Arike, L., Wising, C., Svensson, F., Backhed, F., Hansson, G.C., Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe 18 (2015), 582–592.
35. Kroemer, G., Zitvogel, L., Cancer immunotherapy in 2017: the breakthrough of the microbiota. Nat. Rev. Immunol. 18 (2018), 87–88.
36. Larkin, J., Hodi, F.S., Wolchok, J.D., Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373 (2015), 1270–1271.
37. Lathrop, S.K., Bloom, S.M., Rao, S.M., Nutsch, K., Lio, C.W., Santacruz, N., Peterson, D.A., Stappenbeck, T.S., Hsieh, C.S., Peripheral education of the immune system by colonic commensal microbiota. Nature 478 (2011), 250–254.
38. Letunic, I., Bork, P., Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 44 (2016), W242–W245.
39. Levy, M., Kolodziejczyk, A.A., Thaiss, C.A., Elinav, E., Dysbiosis and the immune system. Nat. Rev. Immunol. 17 (2017), 219–232.
40. Ma, N., Guo, P., Zhang, J., He, T., Kim, S.W., Zhang, G., Ma, X., Nutrients mediate intestinal bacteria-mucosal immune crosstalk. Front. Immunol., 9, 2018, 5.
41. Mantis, N.J., Rol, N., Corthésy, B., Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4 (2011), 603–611.
42. Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J.J., Gajewski, T.F., The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359 (2018), 104–108.
43. Morgan, X.C., Huttenhower, C., Chapter 12: human microbiome analysis. PLoS Comput. Biol., 8, 2012, e1002808.
44. Oh, J.Z., Ravindran, R., Chassaing, B., Carvalho, F.A., Maddur, M.S., Bower, M., Hakimpour, P., Gill, K.P., Nakaya, H.I., Yarovinsky, F., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41 (2014), 478–492.
45. Pabst, O., New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12 (2012), 821–832.
46. Paulos, C.M., Wrzesinski, C., Kaiser, A., Hinrichs, C.S., Chieppa, M., Cassard, L., Palmer, D.C., Boni, A., Muranski, P., Yu, Z., et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J. Clin. Invest. 117 (2007), 2197–2204.
47. Peled, J.U., Devlin, S.M., Staffas, A., Lumish, M., Khanin, R., Littmann, E.R., Ling, L., Kosuri, S., Maloy, M., et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J. Clin. Oncol. 35 (2017), 1650–1659.
48. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., Louis, P., Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 101 (2009), 541–550.
49. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352.
50. Round, J.L., Mazmanian, S.K., Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107 (2010), 12204–12209.
51. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
52. Routy, B., Letendre, C., Enot, D., Chénard-Poirier, M., Mehraj, V., Séguin, N.C., Guenda, K., Gagnon, K., Woerther, P.-L., Ghez, D., Lachance, S., The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology, 6, 2017, e1258506.
53. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol., 14, 2016, e1002533.
54. Sharma, P., Hu-Lieskovan, S., Wargo, J.A., Ribas, A., Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168 (2017), 707–723.
55. Shen, Y., Giardino Torchia, M.L., Lawson, G.W., Karp, C.L., Ashwell, J.D., Mazmanian, S.K., Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12 (2012), 509–520.
56. Shono, Y., Docampo, M.D., Peled, J.U., Perobelli, S.M., Velardi, E., Tsai, J.J., Slingerland, A.E., Smith, O.M., Young, L.F., et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl. Med., 8, 2016, 339ra71.
57. Shortt, C., Hasselwander, O., Meynier, A., Nauta, A., Fernandez, E.N., Putz, P., Rowland, I., Swann, J., Turk, J., Vermeiren, J., Antoine, J.M., Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur. J. Nutr. 57 (2018), 25–49.
58. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
59. Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J.M., Desrichard, A., Walsh, L.A., Postow, M.A., Wong, P., Ho, T.S., et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371 (2014), 2189–2199.
60. Spiljar, M., Merkler, D., Trajkovski, M., The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front. Immunol., 8, 2017, 1353.
61. Spitzer, M.H., Carmi, Y., Reticker-Flynn, N.E., Kwek, S.S., Madhireddy, D., Martins, M.M., Gherardini, P.F., Prestwood, T.R., Chabon, J., Bendall, S.C., et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168 (2017), 487–502.e15.
62. Stary, G., Olive, A., Radovic-Moreno, A.F., Gondek, D., Alvarez, D., Basto, P.A., Perro, M., Vrbanac, V.D., Tager, A.M., Shi, J., et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science, 348, 2015, aaa8205.
63. Taur, Y., Jenq, R.R., Perales, M.A., Littmann, E.R., Morjaria, S., Ling, L., No, D., Gobourne, A., Viale, A., Dahi, P.B., et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124 (2014), 1174–1182.
64. Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y.J., Dubin, K.A., Socci, N.D., Viale, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55 (2012), 905–914.
65. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449 (2007), 804–810.
66. van Bekkum, D.W., Roodenburg, J., Heidt, P.J., van der Waaij, D., Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J. Natl. Cancer Inst. 52 (1974), 401–404.
67. Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
68. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D.P., Pfirschke, C., Engblom, C., Pittet, M.J., et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342 (2013), 971–976.
69. Weaver, C.T., Elson, C.O., Fouser, L.A., Kolls, J.K., The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8 (2013), 477–512.
70. Weber, D., Oefner, P.J., Hiergeist, A., Koestler, J., Gessner, A., Weber, M., Hahn, J., Wolff, D., Stammler, F., Spang, R., et al. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood 126 (2015), 1723–1728.
71. Weber, J.S., Kudchadkar, R.R., Yu, B., Gallenstein, D., Horak, C.E., Inzunza, H.D., Zhao, X., Martinez, A.J., Wang, W., Gibney, G., et al. Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma. J. Clin. Oncol. 31 (2013), 4311–4318.